Anand Sheya, Gogineni S Namratha, Shriraam Mahadevan, Adlyne R Ashirvatham, Asha Ranjan
{"title":"Inherited, Non-CAH Primary Adrenal Insufficiency in Children: A Genetic and Clinical Profile from a Tertiary Care Centre.","authors":"Anand Sheya, Gogineni S Namratha, Shriraam Mahadevan, Adlyne R Ashirvatham, Asha Ranjan","doi":"10.4103/ijem.ijem_22_25","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Primary adrenal insufficiency (PAI) results from inadequate adrenal hormone production due to adrenal cortex dysfunction. While congenital adrenal hyperplasia (CAH) is the most common cause in children, non-CAH causes are rare and often associated with specific genetic mutations. This study aims to explore the genetic, clinical, and biochemical spectrum of non-CAH PAI in South Indian children.</p><p><strong>Methods: </strong>This retrospective study reviewed records of children under 18 years diagnosed with PAI at a tertiary care centre between January 2016 and December 2023. Data on clinical presentation, biochemical parameters, genetic findings, and treatment responses were analysed.</p><p><strong>Results: </strong>Twelve patients (11 index) (7 males, 5 females) with non-CAH PAI were identified, with a median age of 2.5 years at diagnosis. Common symptoms included hyperpigmentation (100%), recurrent infections, gastrointestinal issues, and growth delays. Genetic analysis identified seven distinct mutations: <i>AAAS, MC2R, ABCD1, CYP11A1, NNT, NROB1, and TXNRD2</i>. All 12 patients were initiated on glucocorticoids, and six were also initiated on fludrocortisone.</p><p><strong>Conclusion: </strong>This study highlights the genetic and clinical spectrum of non-CAH PAI in South India, emphasising the importance of early diagnosis and genetic profiling. The findings suggest a high prevalence of consanguinity and specific mutations, underscoring the need for genetic testing in resource-limited settings. Future research should focus on expanding genetic databases and evaluating long-term outcomes to refine treatment strategies and improve patient care.</p>","PeriodicalId":13353,"journal":{"name":"Indian Journal of Endocrinology and Metabolism","volume":"29 4","pages":"440-445"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12410961/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Endocrinology and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijem.ijem_22_25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Primary adrenal insufficiency (PAI) results from inadequate adrenal hormone production due to adrenal cortex dysfunction. While congenital adrenal hyperplasia (CAH) is the most common cause in children, non-CAH causes are rare and often associated with specific genetic mutations. This study aims to explore the genetic, clinical, and biochemical spectrum of non-CAH PAI in South Indian children.
Methods: This retrospective study reviewed records of children under 18 years diagnosed with PAI at a tertiary care centre between January 2016 and December 2023. Data on clinical presentation, biochemical parameters, genetic findings, and treatment responses were analysed.
Results: Twelve patients (11 index) (7 males, 5 females) with non-CAH PAI were identified, with a median age of 2.5 years at diagnosis. Common symptoms included hyperpigmentation (100%), recurrent infections, gastrointestinal issues, and growth delays. Genetic analysis identified seven distinct mutations: AAAS, MC2R, ABCD1, CYP11A1, NNT, NROB1, and TXNRD2. All 12 patients were initiated on glucocorticoids, and six were also initiated on fludrocortisone.
Conclusion: This study highlights the genetic and clinical spectrum of non-CAH PAI in South India, emphasising the importance of early diagnosis and genetic profiling. The findings suggest a high prevalence of consanguinity and specific mutations, underscoring the need for genetic testing in resource-limited settings. Future research should focus on expanding genetic databases and evaluating long-term outcomes to refine treatment strategies and improve patient care.
期刊介绍:
The Indian Journal of Endocrinology and Metabolism (IJEM) aims to function as the global face of Indian endocrinology research. It aims to act as a bridge between global and national advances in this field. The journal publishes thought-provoking editorials, comprehensive reviews, cutting-edge original research, focused brief communications and insightful letters to editor. The journal encourages authors to submit articles addressing aspects of science related to Endocrinology and Metabolism in particular Diabetology. Articles related to Clinical and Tropical endocrinology are especially encouraged. Sub-topic based Supplements are published regularly. This allows the journal to highlight issues relevant to Endocrine practitioners working in India as well as other countries. IJEM is free access in the true sense of the word, (it charges neither authors nor readers) and this enhances its global appeal.